×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CELC – celcuity inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CELC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/20
07:30 am
celc
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Low
Report
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
1/11
01:18 am
celc
Wells Fargo Initiates Coverage On Celcuity Inc. (CELC) [Yahoo! Finance]
Low
Report
Wells Fargo Initiates Coverage On Celcuity Inc. (CELC) [Yahoo! Finance]
1/2
03:41 am
celc
Celcuity (CELC) Surges 662% in 2025 on Breast Cancer Treatment Trial Results [Yahoo! Finance]
Low
Report
Celcuity (CELC) Surges 662% in 2025 on Breast Cancer Treatment Trial Results [Yahoo! Finance]
12/24
11:27 am
celc
Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond [Seeking Alpha]
Low
Report
Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond [Seeking Alpha]
12/17
10:32 am
celc
How Investors Are Reacting To Celcuity (CELC) Gedatolisib's Phase 3 Breast Cancer Data And Safety Profile [Yahoo! Finance]
Low
Report
How Investors Are Reacting To Celcuity (CELC) Gedatolisib's Phase 3 Breast Cancer Data And Safety Profile [Yahoo! Finance]
12/16
09:27 pm
celc
Celcuity (CELC): Fresh Phase 3 Breast Cancer Data Prompts Closer Look at Gedatolisib-Driven Valuation [Yahoo! Finance]
Low
Report
Celcuity (CELC): Fresh Phase 3 Breast Cancer Data Prompts Closer Look at Gedatolisib-Driven Valuation [Yahoo! Finance]
12/13
07:49 am
celc
Celcuity (NASDAQ:CELC) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Medium
Report
Celcuity (NASDAQ:CELC) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
12/12
07:12 am
celc
Celcuity (NASDAQ:CELC) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating on the stock.
Medium
Report
Celcuity (NASDAQ:CELC) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/16
05:31 pm
celc
Form SCHEDULE 13D/A Celcuity Inc. Filed by: Growth Equity Opportunities 18 VGE, LLC
Low
Report
Form SCHEDULE 13D/A Celcuity Inc. Filed by: Growth Equity Opportunities 18 VGE, LLC
1/9
04:44 pm
celc
Form 4 Celcuity Inc. For: Dec 15 Filed by: NIGON RICHARD
Low
Report
Form 4 Celcuity Inc. For: Dec 15 Filed by: NIGON RICHARD
12/9
04:23 pm
celc
Form 4 Celcuity Inc. For: Dec 05 Filed by: Buller Richard E
Low
Report
Form 4 Celcuity Inc. For: Dec 05 Filed by: Buller Richard E
12/8
04:31 pm
celc
Form 4 Celcuity Inc. For: Dec 04 Filed by: Furcht Leo
Medium
Report
Form 4 Celcuity Inc. For: Dec 04 Filed by: Furcht Leo
12/5
05:31 pm
celc
Form 144 Celcuity Inc. Filed by: Buller Richard E
Low
Report
Form 144 Celcuity Inc. Filed by: Buller Richard E
12/3
04:10 pm
celc
Form 4 Celcuity Inc. For: Dec 01 Filed by: Buller Richard E
Medium
Report
Form 4 Celcuity Inc. For: Dec 01 Filed by: Buller Richard E
12/1
05:46 pm
celc
Form 144 Celcuity Inc. Filed by: Buller Richard E
Low
Report
Form 144 Celcuity Inc. Filed by: Buller Richard E
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.
7.9%
4/23 Celcuity Inc. Schedules Release of First Quarter 2020 Financial Results and Conference Call 7.6%
5/8 Celcuity Inc (NASDAQ: CELC) was given a new $36.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 3.2%
7/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 2.8%
5/20 Celcuity Announces Appointment of Leo Furcht to Board of Directors 2.1%
11/7 Q3/2019 9/30/2019 EPS -0.160 ZacksConsensus -0.180 ActVsEst 0.020 - Beat 1.9%
8/8 Celcuity Reports Second Quarter 2019 Financial Results 1.6%
1/13 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 1.5%
2/24 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 1.5%
5/20 Form 4 Celcuity Inc. For: May 16 Filed by: NIGON RICHARD 1.4%
4/23 Celcuity Inc. Schedules Release of First Quarter 2020 Financial Results and Conference Call 7.6%
5/8 Celcuity Inc (NASDAQ: CELC) was given a new $36.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 3.2%
7/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 2.8%
5/20 Celcuity Announces Appointment of Leo Furcht to Board of Directors 2.1%
11/7 Q3/2019 9/30/2019 EPS -0.160 ZacksConsensus -0.180 ActVsEst 0.020 - Beat 1.9%
8/8 Celcuity Reports Second Quarter 2019 Financial Results 1.6%
1/13 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 1.5%
2/24 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 1.5%
5/20 Form 4 Celcuity Inc. For: May 16 Filed by: NIGON RICHARD 1.4%
TOP News Decliners
2/14
Form SC 13G/A Celcuity Inc. Filed by: Sullivan Brian F.
-5.1%
8/1 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $25.00 price target on the stock. -4.3%
3/13 Celcuity Inc (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $36.00. -3.6%
10/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.3%
8/10 Celcuity's (CELC) CEO Brian Sullivan on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.9%
11/20 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -1.1%
7/25 Celcuity Inc. Schedules Release of Second Quarter 2019 Financial Results and Conference Call -1.1%
12/11 Celcuity Presents Results at the 2019 San Antonio Breast Cancer Symposium Evaluating a Sub-Group of PIK3CA WT Breast Cancer Patients Who Have Hyperactive Signaling Tumors Responsive to PI3K Inhibitors -0.9%
11/11 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -0.8%
2/27 Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2019 Financial Results and Conference Call -0.7%
8/1 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $25.00 price target on the stock. -4.3%
3/13 Celcuity Inc (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $36.00. -3.6%
10/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.3%
8/10 Celcuity's (CELC) CEO Brian Sullivan on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.9%
11/20 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -1.1%
7/25 Celcuity Inc. Schedules Release of Second Quarter 2019 Financial Results and Conference Call -1.1%
12/11 Celcuity Presents Results at the 2019 San Antonio Breast Cancer Symposium Evaluating a Sub-Group of PIK3CA WT Breast Cancer Patients Who Have Hyperactive Signaling Tumors Responsive to PI3K Inhibitors -0.9%
11/11 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -0.8%
2/27 Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2019 Financial Results and Conference Call -0.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: